Literature DB >> 12858218

High risk HPV types in southern Iranian patients with cervical cancer.

S Farjadian1, E Asadi, M Doroudchi, A Samsami Dehaghani, S Z Tabei, V P Kumar, A Ghaderi.   

Abstract

This study was undertaken to assess the rate of HPV infection in cervical carcinoma among southern Iranian patients. 101 archival cervical carcinoma tissue samples of a 10 year period were studied for the presence of HPV DNA in southern Iran by a polymerase chain reaction method. In addition, the presence of high risk HPV-16 and HPV-18 genotypes was investigated. In total, 88 (87.1%) of the samples were HPV DNA positive, of which 83 were squamous cell carcinomas and 5 were adenocarcinomas. HPV-16 genotype was detected in 26.7% of HPV positive cervical carcinomas; however, none of the samples were positive for the existence of HPV-18 genotype. Collectively, these results suggest that HPV-16 and HPV-18 are not the frequent high risk HPV types in our patients and circulating HPV types in southern Iranian population are different from many other populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12858218     DOI: 10.1007/bf03033756

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  26 in total

1.  Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City, São Paulo, Brazil.

Authors:  M A Gonçalves; E Massad; M N Burattini; L L Villa
Journal:  Int J STD AIDS       Date:  1999-12       Impact factor: 1.359

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Cervical-cancer screening beyond the year 2000.

Authors:  A Ferenczy; E Franco
Journal:  Lancet Oncol       Date:  2001-01       Impact factor: 41.316

4.  Disruption of cell cycle control by human papillomaviruses with special reference to cervical carcinoma.

Authors:  S. A. Southern; C. S. Herrington
Journal:  Int J Gynecol Cancer       Date:  2000-07       Impact factor: 3.437

5.  Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women.

Authors:  M Chabaud; P Le Cann; V Mayelo; D Leboulleux; A S Diallo; N Enogat; J M Afoutou; P Anthonioz; A M Coll-Seck; P Coursaget
Journal:  J Med Virol       Date:  1996-08       Impact factor: 2.327

6.  Benefits and costs of using HPV testing to screen for cervical cancer.

Authors:  Jeanne S Mandelblatt; William F Lawrence; Sharita Mizell Womack; Denise Jacobson; Bin Yi; Yi-ting Hwang; Karen Gold; James Barter; Keerti Shah
Journal:  JAMA       Date:  2002-05-08       Impact factor: 56.272

7.  HLA-DQBl alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients.

Authors:  Alamtaj Samsami Dehaghani; Ali Amirzargar; Shirin Farjadian; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

8.  Human papillomavirus genotypes in rural Mozambique.

Authors:  X Castellsagué; C Menéndez; M P Loscertales; J R Kornegay; F dos Santos; F X Gómez-Olivé; B Lloveras; N Abarca; N Vaz; A Barreto; F X Bosch; P Alonso
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

9.  A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.

Authors:  Philip E Castle; Sholom Wacholder; Attila T Lorincz; David R Scott; Mark E Sherman; Andrew G Glass; Brenda B Rush; John E Schussler; Mark Schiffman
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

10.  HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness.

Authors:  Gianna Badaracco; Aldo Venuti; Alfonso Sedati; Maria Luisa Marcante
Journal:  J Med Virol       Date:  2002-08       Impact factor: 2.327

View more
  15 in total

Review 1.  HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.

Authors:  Laith J Abu-Raddad; Joshua T Schiffer; Rhoda Ashley; Ghina Mumtaz; Ramzi A Alsallaq; Francisca Ayodeji Akala; Iris Semini; Gabriele Riedner; David Wilson
Journal:  Epidemics       Date:  2010-09-15       Impact factor: 4.396

Review 2.  Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions.

Authors:  Ala-Eddin Al Moustafa; Rana Al-Awadhi; Nabiha Missaoui; Ishag Adam; Raika Durusoy; Lina Ghabreau; Nizar Akil; Hussain Gadelkarim Ahmed; Amber Yasmeen; Ghazi Alsbeih
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Detection of Human Papillomavirus in Cervical Gradings by Immunohistochemistry and Typing of HPV 16 and 18 in High-Grades by Polymerase Chain Reaction.

Authors:  Mrudula Soma; Suhasini Kamaraj
Journal:  J Lab Physicians       Date:  2010-01

4.  The prevalence and pattern of HPV-16 immunostaining in uterine cervical carcinomas in Ethiopian women: a pilot study.

Authors:  Mona M Rashed; Alemayehu Bekele
Journal:  Pan Afr Med J       Date:  2011-03-11

5.  Does oral contraceptive pill increase the risk of abnormal Pap smear?

Authors:  Fariba Binesh; Ali Akhavan; Azar Pirdehghan; Mahnoosh Davoodi
Journal:  Iran J Reprod Med       Date:  2013-09

6.  The Association of High Risk Human Papillomaviruses in Patients With Cervical Cancer: An Evidence Based Study on Patients With Squamous Cell Dysplasia or Carcinoma for Evaluation of 23 Human Papilloma Virus Genotypes.

Authors:  Ahmad Piroozmand; Seyed Mostafa Mostafavi Zadeh; Azita Madani; Reza Soleimani; Reza Nedaeinia; Mohammad Niakan; Amir Avan; Mostafa Manian; Mohammad Moradi; Zahra Eftekhar
Journal:  Jundishapur J Microbiol       Date:  2016-02-17       Impact factor: 0.747

7.  Frequency of Human Papillumavirus among Women with High-Grade Squamous Intraepithelial Lesions and Invasive Cervical Cancer Attending Shahid Beheshti University of Medical Sciences Clinics, Tehran, Iran.

Authors:  Nahid Khodakarami; Afshin Moradi; Hamidreza Mirzaei; Farah Farzaneh; Parvin Yavari; Mohamad Esmaeil Akbari
Journal:  Iran J Public Health       Date:  2014-11       Impact factor: 1.429

8.  Prevalence of HPV Infection and High Risk HPV Genotypes (16, 18), among Monogamous and Polygamous Women, In Zabol, Iran.

Authors:  I Shahramian; Z Heidari; Hr Mahmoudzadeh-Sagheb; A Moradi; F Forghani
Journal:  Iran J Public Health       Date:  2011-09-30       Impact factor: 1.429

9.  Oncogenic human papillomavirus genital infection in southern Iranian women: population-based study versus clinic-based data.

Authors:  Seyed Sajjad Eghbali; Roya Amirinejad; Narges Obeidi; Shiva Mosadeghzadeh; Katayoun Vahdat; Fatemeh Azizi; Raha Pazoki; Zahra Sanjdideh; Zahra Amiri; Iraj Nabipour; Keivan Zandi
Journal:  Virol J       Date:  2012-09-12       Impact factor: 4.099

10.  Prevalence of cervical neoplastic lesions and Human Papilloma Virus infection in Egypt: National Cervical Cancer Screening Project.

Authors:  Howayda S Abd el-All; Amany Refaat; Khadiga Dandash
Journal:  Infect Agent Cancer       Date:  2007-07-04       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.